123 related articles for article (PubMed ID: 11780581)
21. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
22. [Expression with TGFbeta1 in the patients with ulcerative colitis].
Wang YF; Wei B; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):204-6. PubMed ID: 15807267
[TBL] [Abstract][Full Text] [Related]
23. Hemostatic imbalance in active and quiescent ulcerative colitis.
van Bodegraven AA; Schoorl M; Baak JP; Linskens RK; Bartels PC; Tuynman HA
Am J Gastroenterol; 2001 Feb; 96(2):487-93. PubMed ID: 11232695
[TBL] [Abstract][Full Text] [Related]
24. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
25. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
[TBL] [Abstract][Full Text] [Related]
26. Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Vasiliadis T; Giouleme O; Evgenidis N
Hepatogastroenterology; 2007; 54(77):1417-21. PubMed ID: 17708267
[TBL] [Abstract][Full Text] [Related]
27. Epithelial apoptosis: cause or consequence of ulcerative colitis?
Seidelin JB; Nielsen OH
Scand J Gastroenterol; 2009; 44(12):1429-34. PubMed ID: 19958058
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of rectal dialysis to determine intrarectal eicosanoids release in ulcerative colitis.
Casellas F; Borruel N; Papo M; Antolín M; Armengol JR; Malagelada JR
Rev Esp Enferm Dig; 1997 Apr; 89(4):280-8. PubMed ID: 9168661
[TBL] [Abstract][Full Text] [Related]
29. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
30. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
[TBL] [Abstract][Full Text] [Related]
31. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H
Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956
[TBL] [Abstract][Full Text] [Related]
32. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E
Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
[TBL] [Abstract][Full Text] [Related]
33. Elevated breath ethane levels in active ulcerative colitis: evidence for excessive lipid peroxidation.
Sedghi S; Keshavarzian A; Klamut M; Eiznhamer D; Zarling EJ
Am J Gastroenterol; 1994 Dec; 89(12):2217-21. PubMed ID: 7977245
[TBL] [Abstract][Full Text] [Related]
34. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
35. [Local production of eicosanoids in patients with ulcerative colitis].
Lukás K; Lukás M; Jáchymová M
Cas Lek Cesk; 1995 Jan; 134(1):13-7. PubMed ID: 7712517
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
37. Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitis.
Kohno H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Inaba T; Yamamoto K; Okada H; Fujita T; Shiratori Y
J Gastroenterol Hepatol; 2005 Jan; 20(1):73-8. PubMed ID: 15610450
[TBL] [Abstract][Full Text] [Related]
38. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis.
Wiercinska-Drapalo A; Jaroszewicz J; Siwak E; Pogorzelska J; Prokopowicz D
Regul Pept; 2008 Apr; 147(1-3):25-8. PubMed ID: 18201778
[TBL] [Abstract][Full Text] [Related]
39. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
[TBL] [Abstract][Full Text] [Related]
40. Plasma interleukin-18 reflects severity of ulcerative colitis.
Wiercinska-Drapalo A; Flisiak R; Jaroszewicz J; Prokopowicz D
World J Gastroenterol; 2005 Jan; 11(4):605-8. PubMed ID: 15641156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
